CORDIS · 101060201 · HORIZON

STREAMLINE Strengthening regional stem cells based research for advancement of multi modal innovative strategy for modelling neurodevelopmental disorders

Coordinator: INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS)

Neurodevelopmental disorders (NDDs) caused by alterations in early brain development are a group of complex and heterogeneous disorders that give rise to the psychiatric conditions such as autism spectrum disorders, intellectual disability, schizophrenia and bipolar disorder. NDDs have a high socio-economic impact and patients with NDDs and mental health problems are geographically dispersed. Thus, establishment of high capacity regional centres with equivalent research capacity and codes of practice is needed in order to build global research activity. The goals of STREAMLINE are to enhanced…

EU contribution
€1.2M
Total cost
€1.2M
Period
2022-07-01 → 2025-06-30
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-CSA
Call
HORIZON-WIDERA-2021-ACCESS-02
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €1.2M awarded to the consortium. The project runs over approximately 3 years from 2022-07-01 to 2025-06-30.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
What is the EU contribution?
The European Commission contributes €1.2M toward a total project budget of €1.2M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2021-ACCESS-02.
Who coordinates the project?
The project is coordinated by INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS).
What is the project timeline?
The project runs from 2022-07-01 to 2025-06-30 — approximately 3 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101060201.